Cancer cells perform tricks for self-destruction without the use of any drugs, according to a new experimental treatment report, offering new hope of winning the war on different types of disease.
Treatment involves a nanoparticle coated in an amino acid called L-phenylalanine. The chemical is not naturally produced in the body, but is derived from meat and dairy products that humans consume.
L-phenylalanine is a complete bite because it is a major amino acid cancer cells need to grow and spread in the human body, which is destructive in the process.
The novel new treatment has proved to be incredibly successful on mice. The secret is the nanoparticle nanoscopic phenylalanine porcine amino acid mimic or nano-PPAM for short.
Nano-PPAAM stimulates the overproduction of reactive oxygen species (ROS) that cause a cascade effect within cancer cells, killing them while damaging the surrounding, healthy cells.
“Against conventional wisdom, our approach is to use nanometry instead of medicine [of] As a drug carrier, ” Says Dalton Tay, a physicist at Nanyang Technological University in Singapore.
Also on rt.com
Cancer charities in the UK are warning of a covid-induced drop of around 50%, but scientists are concerned that the virus itself could cause more tumors.
This method kills about 80 percent of breast, skin and gastric cancer cells in rats, with leading chemotherapy treatment but without the nasty side effects. Research in nanoparticles has generally focused on using it not as a treatment but as a delivery mechanism for drugs.
Nevertheless, there is a long range of regulatory barriers to overcoming treatment before it becomes available to human patients.
If it passes unilaterally in clinical trials, it will also help fight drug-resistant, recurrent forms of cancer, and make a scare of hope possible; Without fighting drugs, cancer has nothing to do with resistance.
Also on rt.com
Surprising Discovery: Combined Russian / American Covid-19 Research Leads to Success in Treating Children’s Cancer
Think your friends would be interested? Share this story!
